focus -WSS

focus

author：comprehensive 2025-10-01 21:35:28 - browse：948

Have you ever taken phenylephrine for a stuffed-up nose and then felt better? If so, you might have been perplexed when Food and Drug Administration experts recently said that that the drug — which is in some versions of DayQuil, Sudafed, and other medicines — is no more effective than a placebo.

But to Michael H. Bernstein, an assistant professor of diagnostic imaging at the Warren Alpert Medical School of Brown University, it all makes sense. Bernstein says that “no better than a placebo” still means that it works, sort of. “If we expect to feel better, then we probably will,” he told me. And that complicates the idea of what medical treatment “works.”

On this episode of the “First Opinion Podcast,” we discuss the placebo effect and its counterpart, the “nocebo effect” — if you tell patients something will make them feel worse, it generally comes true. “You’re better off hearing from a doctor something to the effect of 3 out of 4 patients who take this drug have no side effects at all versus 25% of people who take this drug do get side effects,” he said.

Bernstein also shared the delightful story of how he got into the “medical expectations” field, which started with an experiment in which he had to convince underage students that they were drinking alcohol when they weren’t.

Our conversation was based on a First Opinion Bernstein recently wrote with Grayson L. Baird, “Phenylephrine is no better than a placebo. What if that’s still better than nothing?”

Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Spotify, Google Play, or wherever you get your podcasts.

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： Medicare Advantage plans can’t deny care with AI, CMS warns

leisure time

WSS

As obesity drug market grows, telehealth companies court payers

Novo Holdings to buy drug manufacturer Catalent in $16.5B deal

How to make over

Updated Covid vaccine has 54% effectiveness, new study suggests

Wegovy improves function in certain heart failure patients

Why CTE doesn’t keep Americans from enjoying the Super Bowl

focus

focus

hotspot

Psychedelics group wrestles with new pharma identity

Adopting new red light myopia treatments may be short

What does generative AI mean for health care? We asked experts

DeSantis wants to import drugs. Biden’s FDA blasted his plan

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Study: Spinal cord stimulation helps patients with paralysis walk again

Virginia high school admissions case could be legal follow

A protest over insulin prices is seen as a fight for life

Supreme Court strikes down use of affirmative action

Can U.S. cancer drug shortages be fixed?

entertainment

Vivek Ramaswamy made waves in the debate, much as in biotech

Meadows told special counsel he could not recall Trump ever declassifying Mar

Surgery pushed Ben Carson to fame

Drugmakers bet big on mRNA for cancer. Why's Biden going in?

Kellogg’s is going to war over Mexico’s nutrition label rules

Gritstone Bio's cancer vaccine test, and more on Novartis' deal

leisure time

focus

Wikipedia

explore